arrow_back Trending Legislation
Share share

Study on Chemical Hair Straighteners and Uterine Cancer Risk

This Act mandates a detailed government study on the potential link between the use of chemical hair straighteners and the increased incidence of uterine cancer. The study will specifically focus on women of color, where higher rates of this cancer have been observed. The goal is to determine if the Food and Drug Administration (FDA) should impose new safety testing requirements on manufacturers of these products, potentially enhancing consumer safety.
Key points
Directs the Department of Health and Human Services (HHS) to conduct a study on the relationship between chemical hair straighteners and uterine cancer.
The study must specifically focus on the increased incidence of uterine cancer among women of color.
The research will assess whether the FDA should impose additional safety testing requirements on hair straightener manufacturers.
A final report detailing the study results must be submitted to Congress within 2 years of the Act's enactment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Uterine Cancer Study Act of 2024
Print number: HR 9782
Sponsor: Rep. Clarke, Yvette D. [D-NY-9]
Process start date: 2024-09-24